Ace Vision Group Names Rob Kissling, MD, as Chief Medical Officer
Ace Vision Group announced that it has named Rob Kissling, MD, as Chief Medical Officer.
Dr. Kissling has more than 20 years of experience integrating clinical development, medical strategy, and business planning to develop and commercialize devices and medicines for ophthalmology. His tenure has included companies such as Pharmacia, Pfizer, and Novartis. Most recently, he served as Vice President of Clinical and Medical Affairs at Bausch + Lomb, where he oversaw medical development of the company’s pharmaceutical, surgical, and consumer product portfolio.
Explore More Articles
Treatment landscape for presbyopia evolving toward noninvasive options
Noninvasive or minimally invasive approaches may be the solution for presbyopia before the onset of age-related cataract and a way to address the increasing need to perform close-range tasks. “The treatments that are currently available have not met our needs,” OSN Cornea/External Disease Board Member Eric D. Donnenfeld, MD, said. “Glasses are an inconvenience. Contact lenses cause …
read moreEmerging medical and surgical presbyopic treatments
Ophthalmologists have several options at their disposal for the treatment of presbyopia, according to Elizabeth Yeu, MD, a partner at Virginia Eye Consultants and an assistant professor at Eastern Virginia Medical School in Norfolk. Speaking recently at the virtual 2022 Toronto Cataract Course, Yeu noted that innovation is advancing in presbyopia correction. “We have spent …
read moreUnlocking the recovery of dynamic range of focus with microporation therapeutics
Laser Scleral Microporation (LSM) is a therapy which represents the first biomechanical solution to the biomechanical problems of progressive presbyopia. The therapy is performed using the VisioLite® Ophthalmic Laser system developed by Ace Vision Group (AVG). Today, having no biomechanical option able to meet the loss of dynamic range of focus (DRoF) that occurs with progressive …
read more